Innovator IBD 50 ETF (FFTY): Price and Financial Metrics ETF
FFTY Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $29.10 | 52-week high | $34.26 |
Prev. close | $29.00 | 52-week low | $22.91 |
Day low | $28.92 | Volume | 38,842 |
Day high | $29.38 | Avg. volume | 129,212 |
50-day MA | $26.92 | Dividend yield | 0.89% |
200-day MA | $28.03 |
FFTY Stock Price Chart Interactive Chart >
Innovator IBD 50 ETF (FFTY) ETF Bio
The investment objective of the Innovator IBD 50 ETF seeks long-term capital appreciation. The fund selects its components from the stocks included in the growth-oriented IBD 50 Index and re-weighting them using a proprietary ranking system.
FFTY ETF Info
Issuer | Innovator Capital Management |
Expense Ratio | 0.8% |
Underlying Index | IBD 50 Index |
Asset Class | Equity |
Sector | Managed ETFs |
Assets Under Management (AUM) | 65.22K |
Net Asset Value (NAV) | $28.99 |
Options? | Yes |
Total Holdings | 52 |
FFTY Top Holdings
Symbol | Company | % of Total |
DAVE | Dave Inc | 4.61% |
ROOT | Root Inc/OH | 3.66% |
PLTR | Palantir Technologies Inc | 3.61% |
TVTX | Travere Therapeutics Inc | 3.59% |
HIMS | Hims & Hers Health Inc | 3.56% |
DOCS | Doximity Inc | 3.53% |
AGX | Argan Inc | 3.43% |
AXON | Axon Enterprise Inc | 3.33% |
HOOD | Robinhood Markets Inc | 3.32% |
FFTY Price Returns
1-mo | 10.81% |
3-mo | -13.44% |
6-mo | 3.52% |
1-year | 6.72% |
3-year | -0.18% |
5-year | -3.51% |
YTD | 1.78% |
2024 | 18.36% |
2023 | 12.40% |
2022 | -51.08% |
2021 | 11.92% |
2020 | 18.20% |
FFTY Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |